Colistin and tigecycline resistance in carbapenemase-producing Gram-negative bacteria: emerging resistance mechanisms and detection methods
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Colistin and tigecycline resistance in carbapenemase-producing Gram-negative bacteria: emerging resistance mechanisms and detection methods
Authors
Keywords
-
Journal
JOURNAL OF APPLIED MICROBIOLOGY
Volume 121, Issue 3, Pages 601-617
Publisher
Wiley
Online
2016-05-07
DOI
10.1111/jam.13169
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study
- (2016) Yi-Yun Liu et al. LANCET INFECTIOUS DISEASES
- The Molecular Epidemiology and Genetic Environment of Carbapenemases Detected in Africa
- (2016) John Osei Sekyere et al. Microbial Drug Resistance
- Colistin-Resistant Acinetobacter baumannii Clinical Strains with Deficient Biofilm Formation
- (2015) Konstantina Dafopoulou et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In vitro Activity of Colistin in Combination with Tigecycline against Carbapenem-Resistant Acinetobacter baumannii Strains Isolated from Patients with Ventilator-Associated Pneumonia
- (2015) Aytekin Cikman et al. International Journal of Medical Sciences
- Review of established and innovative detection methods for carbapenemase-producing Gram-negative bacteria
- (2015) J. Osei Sekyere et al. JOURNAL OF APPLIED MICROBIOLOGY
- Elucidation of the RamA Regulon in Klebsiella pneumoniae Reveals a Role in LPS Regulation
- (2015) Shyamasree De Majumdar et al. PLoS Pathogens
- Three Dimensional Checkerboard Synergy Analysis of Colistin, Meropenem, Tigecycline against Multidrug-Resistant Clinical Klebsiella pneumonia Isolates
- (2015) Claudia Stein et al. PLoS One
- IS5Element Integration, a Novel Mechanism for RapidIn VivoEmergence of Tigecycline Nonsusceptibility in Klebsiella pneumoniae
- (2014) Lindsey E. Nielsen et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In VitroandIn VivoActivities of Tigecycline-Colistin Combination Therapies against Carbapenem-Resistant Enterobacteriaceae
- (2014) Jonathan W. Betts et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The difficult-to-control spread of carbapenemase producers among Enterobacteriaceae worldwide
- (2014) P. Nordmann et al. CLINICAL MICROBIOLOGY AND INFECTION
- Colistin resistance superimposed to endemic carbapenem-resistant Klebsiella pneumoniae: a rapidly evolving problem in Italy, November 2013 to April 2014
- (2014) M. Monaco et al. Eurosurveillance
- Colistin resistance in Klebsiella pneumoniae
- (2014) Young-Mi Ah et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Biofilm formation and susceptibility to gentamicin and colistin of extremely drug-resistant KPC-producing Klebsiella pneumoniae
- (2014) Livnat Naparstek et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Tigecycline in treatment of multidrug-resistant Gram-negative bacillus urinary tract infections: a systematic review
- (2014) K. Brust et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Unexpected Tigecycline Resistance AmongAcinetobacter baumanniiIsolates: High Minor Error Rate by Etest
- (2014) C. Kulah et al. JOURNAL OF CHEMOTHERAPY
- Global antibiotic consumption 2000 to 2010: an analysis of national pharmaceutical sales data
- (2014) Thomas P Van Boeckel et al. LANCET INFECTIOUS DISEASES
- Worldwide Dissemination of the NDM-Type Carbapenemases in Gram-Negative Bacteria
- (2014) Laurent Dortet et al. Biomed Research International
- Mechanisms of polymyxin resistance: acquired and intrinsic resistance in bacteria
- (2014) Abiola O. Olaitan et al. Frontiers in Microbiology
- RND-Type Efflux Pumps in Multidrug-Resistant Clinical Isolates of Acinetobacter baumannii: Major Role for AdeABC Overexpression and AdeRS Mutations
- (2013) Eun-Jeong Yoon et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Characterization of Porin Expression in Klebsiella pneumoniae Carbapenemase (KPC)-Producing K. pneumoniae Identifies Isolates Most Susceptible to the Combination of Colistin and Carbapenems
- (2013) Jae H. Hong et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Biological Cost of Different Mechanisms of Colistin Resistance and Their Impact on Virulence in Acinetobacter baumannii
- (2013) Alejandro Beceiro et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Synergistic Activity of Colistin plus Rifampin against Colistin-Resistant KPC-Producing Klebsiella pneumoniae
- (2013) Carlo Tascini et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In vitro activity of tigecycline and comparators against Gram-positive and Gram-negative isolates collected from the Middle East and Africa between 2004 and 2011
- (2013) Souha S. Kanj et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Tigecycline susceptibility in Klebsiella pneumoniae and Escherichia coli causing neonatal septicaemia (2007–10) and role of an efflux pump in tigecycline non-susceptibility
- (2013) Subhasree Roy et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Decreased susceptibility to tigecycline in Acinetobacter baumannii mediated by a mutation in trm encoding SAM-dependent methyltransferase
- (2013) Q. Chen et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases
- (2013) L Silvia Munoz-Price et al. LANCET INFECTIOUS DISEASES
- Retrospective evaluation of colistin versus tigecycline for the treatment of Acinetobacter baumannii and/or carbapenem-resistant Enterobacteriaceae infections
- (2012) Kimberly Ku et al. AMERICAN JOURNAL OF INFECTION CONTROL
- Bactericidal Activity of Multiple Combinations of Tigecycline and Colistin against NDM-1-Producing Enterobacteriaceae
- (2012) Mahableshwar Albur et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- High rate of colistin resistance among patients with carbapenem-resistant Klebsiella pneumoniae infection accounts for an excess of mortality
- (2012) A. Capone et al. CLINICAL MICROBIOLOGY AND INFECTION
- The emergence of clinical resistance to tigecycline
- (2012) Yan Sun et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Emergence of OXA-48 and OXA-181 Carbapenemases among Enterobacteriaceae in South Africa and Evidence ofIn VivoSelection of Colistin Resistance as a Consequence of Selective Decontamination of the Gastrointestinal Tract
- (2012) Adrian J. Brink et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Comparative Evaluation of Tigecycline Susceptibility Testing Methods for Expanded-Spectrum Cephalosporin- and Carbapenem-Resistant Gram-Negative Pathogens
- (2012) O. Zarkotou et al. JOURNAL OF CLINICAL MICROBIOLOGY
- PhoQ Mutations Promote Lipid A Modification and Polymyxin Resistance of Pseudomonas aeruginosa Found in Colistin-Treated Cystic Fibrosis Patients
- (2011) Amanda K. Miller et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Outbreak of KPC-3-producing, and colistin-resistant, Klebsiella pneumoniae infections in two Sicilian hospitals
- (2011) M.L. Mezzatesta et al. CLINICAL MICROBIOLOGY AND INFECTION
- Klebsiella pneumoniae: development of a mixed population of carbapenem and tigecycline resistance during antimicrobial therapy in a kidney transplant patient
- (2011) C. Rodríguez-Avial et al. CLINICAL MICROBIOLOGY AND INFECTION
- Treatment and outcomes in carbapenem-resistant Klebsiella pneumoniae bloodstream infections
- (2011) Elizabeth A. Neuner et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Comparison of Polymyxin B, Tigecycline, Cefepime, and Meropenem MICs for KPC-Producing Klebsiella pneumoniae by Broth Microdilution, Vitek 2, and Etest
- (2011) A. Lat et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Evaluation of Etest To Determine Tigecycline MICs for Enterobacter Species
- (2010) J. Cohen Stuart et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Overexpression of the adeB Gene in Clinical Isolates of Tigecycline-Nonsusceptible Acinetobacter baumannii without Insertion Mutations in adeRS
- (2010) J.-R. Sun et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Outbreak of Colistin-Resistant, Carbapenem-ResistantKlebsiella pneumoniaein Metropolitan Detroit, Michigan
- (2010) Dror Marchaim et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Colistin Resistance in Acinetobacter baumannii Is Mediated by Complete Loss of Lipopolysaccharide Production
- (2010) J. H. Moffatt et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Tigecycline activity: low resistance rates but problematic disc breakpoints revealed by a multicentre sentinel survey in the UK
- (2010) R. Hope et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Influence of Media and Testing Methodology on Susceptibility to Tigecycline of Enterobacteriaceae with Reported High Tigecycline MIC
- (2010) M. Torrico et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Alterations in Two-Component Regulatory Systems of phoPQ and pmrAB Are Associated with Polymyxin B Resistance in Clinical Isolates of Pseudomonas aeruginosa
- (2009) K. Barrow et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Klebsiella pneumoniae AcrAB Efflux Pump Contributes to Antimicrobial Resistance and Virulence
- (2009) E. Padilla et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Resistance Plasmid Families in Enterobacteriaceae
- (2009) A. Carattoli ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Influence of testing methodology on the tigecycline activity profile against presumably tigecycline-non-susceptible Acinetobacter spp.
- (2009) M. Casal et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Tigecycline for the treatment of multidrug-resistant Enterobacteriaceae: a systematic review of the evidence from microbiological and clinical studies
- (2008) Theodoros Kelesidis et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- In Vitro Activity of Tigecycline against Gram-Positive and Gram-Negative Pathogens as Evaluated by Broth Microdilution and Etest
- (2008) C. M. Pillar et al. JOURNAL OF CLINICAL MICROBIOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started